Betamethasone / Calcipotriene Topical Dosage
Medically reviewed by Drugs.com. Last updated on Dec 9, 2024.
Applies to the following strengths: 0.064%-0.005%
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Psoriasis
OINTMENT:
- Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
- The maximum weekly dose should not exceed 100 g.
- Treatment of more than 30% body surface area is not recommended.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
TOPICAL SUSPENSION:
- Apply to affected area(s) once daily for up to 8 weeks.
- The maximum weekly dose should not exceed 100 g.
- Treatment of more than 30% body surface area is not recommended.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
FOAM AEROSOL:
- Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
- Do not use more than 60 g every 4 days.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
Uses:
- Ointment formulation: For the topical treatment of plaque psoriasis in patients 12 years of age and older
- Topical suspension: For plaque psoriasis of the scalp and body in patients 18 years and older
- Foam aerosol: For the topical treatment of plaque psoriasis in patients 18 years of age and older
Usual Pediatric Dose for Psoriasis
OINTMENT:
12 years and older:
- Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
- The maximum weekly dose should not exceed 60 g.
- Treatment of more than 30% body surface area is not recommended.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
TOPICAL SUSPENSION:
12 years and older:
- Apply to affected area(s) once daily for up to 8 weeks.
- The maximum weekly dose should not exceed 60 g.
- Treatment of more than 30% body surface area is not recommended.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
FOAM AEROSOL:
12 years and older:
- Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
- Do not use more than 60 g every 4 days.
- Discontinue therapy when control is achieved.
- Do not use with occlusive dressings unless directed by a physician.
- Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
Uses:
- Ointment and foam formulations: For the topical treatment of plaque psoriasis in patients 12 years of age and older
- Topical suspension: For plaque psoriasis of the scalp in patients 12 to 17 years
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- None
Safety and efficacy have not been established in patients younger than 12 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Rub product in gently and completely.
- Patients should wash their hands after application of the product.
- Avoid excessive exposure to either natural or artificial sunlight. Physicians may wish to limit or avoid use of phototherapy in such patients.
- Do not use this drug combination orally, ophthalmically, or intravaginally.
- Instruct patients to shake bottle prior to using the topical suspension or foam.
General:
This topical drug combination may cause eye irritation. Eye exposure should be avoided.
Frequently asked questions
More about betamethasone / calcipotriene topical
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (133)
- Side effects
- During pregnancy
- Drug class: topical antipsoriatics
- En español
Patient resources
Other brands
Wynzora, Enstilar, Taclonex, Taclonex Scalp
Professional resources
- Calcipotriene and Betamethasone Ointment prescribing information
- Calcipotriene and Betamethasone Topical Suspension (FDA)
Other brands
Related treatment guides
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Vtama
Vtama (tapinarof) is a steroid-free, once-daily cream used to treat plaque psoriasis and atopic ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Methylprednisolone
Methylprednisolone is used to treat conditions such as allergies, arthritis, lupus and ulcerative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.